<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03182985</url>
  </required_header>
  <id_info>
    <org_study_id>UCSD IRB 170504</org_study_id>
    <nct_id>NCT03182985</nct_id>
  </id_info>
  <brief_title>The Impact of Time Restricted Feeding (TRF) in Improving the Health of Patients With Metabolic Syndrome</brief_title>
  <official_title>The Impact of Time Restricted Feeding (TRF) in Improving the Health of Patients With Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Salk Institute for Biological Studies</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators intend to measure the health impact of a dietary intervention known as time&#xD;
      restricted feeding (TRF) on patients with metabolic syndrome (three or more of: increased&#xD;
      waist circumference, abnormal cholesterol levels, elevated blood pressure, or elevated blood&#xD;
      sugar). The investigators will enroll patients with metabolic syndrome who eat for ≥ 14 hours&#xD;
      per day and will ask participants to reduce daily oral intake to 10 hours per day. The&#xD;
      investigators will assess the impact of this dietary change using measures obtained before&#xD;
      and after a 12 week intervention period, including body mass index, blood pressure, various&#xD;
      lab parameters and blood sugar levels (assessed using a continuous glucose monitor). The&#xD;
      investigators will assess for compliance with TRF using a Smart Phone application&#xD;
      (myCircadianClock (mCC) app).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 28, 2017</start_date>
  <completion_date type="Actual">August 5, 2019</completion_date>
  <primary_completion_date type="Actual">January 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean blood glucose</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measured using a continuous glucose monitoring (CGM) device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin, triglycerides, hs-CRP levels</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measured by blood test</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Weight Loss</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>Time Restricted Feeding</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will reduce daily oral intake to 10 hours per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Time Restricted Feeding</intervention_name>
    <description>Participants will reduce the amount of time they eat to 10 hours per day and will log their dietary intake using a smartphone application.</description>
    <arm_group_label>Time Restricted Feeding</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Waist circumference ≥ 102 cm (Men) or ≥ 88 cm (Women).&#xD;
&#xD;
          2. Triglycerides ≥ 150 mg/dL (or on drug treatment for elevated triglycerides).&#xD;
&#xD;
          3. Reduced HDL-C &lt; 40 mg/dL (Men), &lt; 50 mg/dL (Women) (or on drug treatment for reduced&#xD;
             HDL-C).&#xD;
&#xD;
          4. Elevated blood pressure, systolic blood pressure ≥ 130 mmHg and/or diastolic blood&#xD;
             pressure ≥ 85 mmHg (or treatment with antihypertensive drug with history of&#xD;
             hypertension).&#xD;
&#xD;
          5. Elevated fasting glucose ≥ 100 mg/dL (or drug treatment of elevated blood glucose).&#xD;
&#xD;
          6. Age ≥18 years.&#xD;
&#xD;
          7. If patients are on cardiovascular medications (HMG coenzyme A reductase inhibitors&#xD;
             (statins), other lipid modifying drugs (including over the counter drugs such as red&#xD;
             yeast rice and fish oil), anti-hypertensive, anti-diabetes drugs), no dose adjustments&#xD;
             will be allowed during the study period&#xD;
&#xD;
          8. Own a Smartphone with Apple iOperating System (OS) or Android OS. Baseline eating&#xD;
             period is ≥ 14 hours per day.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant or breast-feeding.&#xD;
&#xD;
          2. Caregiver for a dependent requiring frequent nocturnal care/sleep interruptions. Shift&#xD;
             workers with variable (e.g. nocturnal) hours.&#xD;
&#xD;
          3. Planned international travel during the study period.&#xD;
&#xD;
          4. Active tobacco abuse or history of treatment for alcohol abuse,&#xD;
&#xD;
          5. Known inflammatory and/or rheumatologic disease,&#xD;
&#xD;
          6. Known history of familial hypercholesterolemia,&#xD;
&#xD;
          7. History of major adverse cardiovascular event within the past 1 year (acute coronary&#xD;
             syndrome (ACS), percutaneous coronary intervention, coronary artery bypass graft&#xD;
             surgery, hospitalization for congestive heart failure, stroke/transient ischemic&#xD;
             attack (TIA))&#xD;
&#xD;
          8. Uncontrolled arrhythmia (i.e. rate-controlled atrial fibrillation/atrial flutter are&#xD;
             not exclusion criteria)&#xD;
&#xD;
          9. History of sudden cardiac death (SCD) or implantable cardiac defibrillator (ICD)&#xD;
             implantation for any reason,&#xD;
&#xD;
         10. Known history of thyroid or adrenal disease,&#xD;
&#xD;
         11. Any history of malignancy,&#xD;
&#xD;
         12. Known history of type I diabetes,&#xD;
&#xD;
         13. Known history of major immune disease,&#xD;
&#xD;
         14. Eating disorder or bile syndrome,&#xD;
&#xD;
         15. History of cirrhosis&#xD;
&#xD;
         16. History of stage 4 or 5 chronic kidney disease or requiring dialysis&#xD;
&#xD;
         17. History of chronic obstructive pulmonary disease (COPD)&#xD;
&#xD;
         18. Known active infectious diseases,&#xD;
&#xD;
         19. Currently enrolled in a weight-loss or weight-management program,&#xD;
&#xD;
         20. On a special or prescribed diet for other reasons (e.g. Celiac disease),&#xD;
&#xD;
         21. Currently taking any medication that is meant for, or has known effect on, appetite,&#xD;
&#xD;
         22. Any history of surgical intervention for weight management,&#xD;
&#xD;
         23. History of venous thromboembolism.&#xD;
&#xD;
         24. Uncontrolled psychiatric disorder (including history of hospitalization for&#xD;
             psychiatric illness)&#xD;
&#xD;
         25. History of known clotting or bleeding disorder(s)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pam Taub, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSD</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Chaix A, Zarrinpar A, Miu P, Panda S. Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab. 2014 Dec 2;20(6):991-1005. doi: 10.1016/j.cmet.2014.11.001.</citation>
    <PMID>25470547</PMID>
  </reference>
  <reference>
    <citation>Gill S, Le HD, Melkani GC, Panda S. Time-restricted feeding attenuates age-related cardiac decline in Drosophila. Science. 2015 Mar 13;347(6227):1265-9. doi: 10.1126/science.1256682.</citation>
    <PMID>25766238</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>June 5, 2017</study_first_submitted>
  <study_first_submitted_qc>June 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2017</study_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Pam Taub, MD</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

